ArticleAnnals of Indian Academy of Neurology2025
A Clinical Study on the Utility of Muscle Biopsy in Patients with Suspected Myopathy.
Article in Annals of Indian Academy of Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesThe role of muscle biopsy needs to be redefined in an era where genetic studies have largely supplanted the need for a pathological diagnosis. The objective of the study was to evaluate the utility of muscle biopsy in suspected myopathies in terms of diagnostic confirmation and modifying therapy in a developing country.
methodsWe conducted a retrospective observational study of patients who underwent muscle biopsy in our center between April 2017 and 2019. The diagnostic utility and therapeutic impact of muscle biopsy were assessed descriptively and using an ordinal score. We further analyzed the correlation of the pathological diagnosis with the genetic and immunological data.
resultsAmong the 70 patients included in the study over a 2-year period, 33 (47.1%) were aged 18 years or less and the mean age was 23.4 (±16.2) years. A specific diagnosis or diagnostic category could be established in 39 (55.7%) of all patients and 21 (63.6%) among pediatric patients by muscle biopsy. The most common categories were muscular dystrophies in 27 (38.6%) patients and inflammatory myopathies in seven (10%) patients. Mitochondrial myopathy was confirmed in two (2.9%), while three (4.3%) had other specific diagnosis and 31 (44.2%) had indeterminate/normal biopsy reports. Muscle biopsy confirmed the pre-biopsy diagnosis in 29 (41.4%) patients and changed the clinical diagnosis in 16 (22.9%) patients. Category-wise, the change in pre-biopsy diagnosis was significant only in suspected mitochondrial myopathies, but not in other categories.
conclusionsMuscle biopsy helped in securing a specific diagnosis in approximately one-half of the patients. This study underscores the enduring relevance of muscle biopsy in settings where resources for advanced genetic testing and data analysis are constrained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.